What is CONMED's revenue?

CONMED (CNMD) generated $1.4B in revenue over the trailing twelve months, up 4.1% year over year.

Is CONMED profitable?

CONMED reported $54.8M in net income over the trailing twelve months, a 4.0% net margin.

What are CONMED's profit margins?

Gross margin is 55.2% and operating margin is 8.2%, with a 4.0% net margin.

What is CONMED's earnings per share?

CONMED's diluted EPS over the trailing twelve months is $1.77.

Where does CONMED's income statement data come from?

Every line is extracted from CONMED's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

CONMED CNMD Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Total revenue	$1.37B+5.2%	$1.31B+5.0%	$1.24B+19.1%	$1.05B+3.4%
Total cost of revenue	$624.25M+8.8%	$573.98M+1.0%	$568.5M+19.9%	$474.23M+7.1%
Gross profit	$750.48M+2.4%	$733.03M+8.4%	$676.25M+18.4%	$571.25M+0.6%
Gross margin	54.6%-1.5pp	56.1%+1.8pp	54.3%-0.3pp	54.6%-1.6pp
Research and development	$55.89M+2.7%	$54.43M+3.5%	$52.6M+11.6%	$47.15M+8.2%
Selling, general and administrative	$591.97M+23.8%	$478.28M-4.9%	$503.04M+10.8%	$454.04M+9.5%
Selling and marketing	$67.25M+2.9%	$65.34M+7.3%	$60.92M+8.7%	$56.03M—
General and administrative	$131.97M+12.3%	$117.46M+5.6%	$111.24M+15.7%	$96.11M—
Compensation and benefits	$28.32M+10.8%	$25.56M+5.4%	$24.26M+11.6%	$21.73M+33.0%
Depreciation and amortization	$35.2M+1.4%	$34.7M-1.4%	$35.2M+4.5%	$33.7M+1.5%
Other operating expenses	$647.85M+21.6%	$532.71M-4.1%	$555.64M+10.9%	$501.19M+9.4%
Total operating expenses	$647.85M+21.6%	$532.71M-4.1%	$555.64M+10.9%	$501.19M+9.4%
Operating income	$102.62M-48.8%	$200.33M+66.1%	$120.6M+69.5%	$71.15M-35.2%
Operating margin	7.5%-7.9pp	15.3%+5.6pp	9.7%+2.9pp	6.8%-4.1pp
Interest expense	$31.09M-16.6%	$37.3M-6.2%	$39.78M+37.6%	$28.91M-18.5%
Other income (expense), net	$170K-94.0%	$2.83M-82.2%	$15.94M+88.0%	$8.48M—
Income before income taxes	$71.12M-56.4%	$163.03M+102%	$80.83M+214%	-$70.86M-197%
Income tax expense	$24.06M-21.4%	$30.61M+87.0%	$16.37M—	——
Net income	$47.06M-64.5%	$132.42M+105%	$64.46M—	——
Net margin	3.4%-6.7pp	10.1%+5.0pp	5.2%—	——
Diluted earnings per share	$1.51-64.4%	$4.24+108%	$2.04—	——
Basic earnings per share	$1.51-64.8%	$4.29+103%	$2.11—	——
Weighted-average shares, diluted	124.4M-0.2%	124.6M-1.3%	126.2M+0.1%	126.1M-1.7%
Weighted-average shares, basic	123.9M+0.5%	123.3M+0.6%	122.6M+2.4%	119.7M+2.8%
Other expenses	$418K—	$0—	$0—	——
Share-based compensation expense related to employee stock plans	$28.32M+10.8%	$25.56M+5.4%	$24.26M+11.6%	$21.73M+33.0%
Amortization Of Financing Costs	$5.65M-0.9%	$5.7M-5.9%	$6.06M+23.4%	$4.91M+31.8%
Amortization of capitalized software and acquired intangible assets	$35.2M+1.4%	$34.7M-1.4%	$35.2M+4.5%	$33.7M+1.5%
Stock options excluded as their inclusion would be anti-dilutive (in shares)	15.4M+23.2%	12.5M+68.9%	7.4M+155%	2.9M+26.1%
Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1	$22.95M+154%	-$42.27M-1,646%	-$2.42M-196%	$2.52M—
Software amortization expense	$1.2M-14.3%	$1.4M-17.6%	$1.7M-19.0%	$2.1M-36.4%
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation	$17.91M—	——	——	——
Dividends declared (in dollars per share)	$0.60-25.0%	$0.800.0%	$0.800.0%	$0.800.0%
Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest	$59.62M-51.8%	$123.74M+71.5%	$72.15M—	——
Revenue recognized that was included in deferred income at the beginning of the period	$14.4M+3.6%	$13.9M+11.2%	$12.5M+8.7%	$11.5M+11.7%
Federal	$5.73M+40.4%	$4.08M+97.7%	$2.07M+2,008%	$98K+201%
Foreign	$12.75M+11.4%	$11.45M+17.1%	$9.78M-30.6%	$14.08M+99.9%
Current State And Local Tax Expense Benefit	$2.05M-28.6%	$2.88M-24.9%	$3.83M+142%	$1.58M+160%
Federal	$3.97M-61.7%	$10.35M+266%	$2.83M+169%	-$4.1M-218%
Deferred Foreign Income Tax Expense Benefit	-$1.4M-219%	$1.17M+195%	-$1.23M-298%	-$310K+83.8%
Deferred taxes	$3.52M-71.1%	$12.2M+1,643%	$700K+112%	-$6.04M—
State	$953K+39.9%	$681K+176%	-$893K+45.4%	-$1.64M-213%
Defined Benefit Plan, Amortization of Gain (Loss)	-$1.42M+11.0%	-$1.59M+25.3%	-$2.13M+17.9%	-$2.59M+22.1%
Defined Benefit Plan Amounts Recognized In Other Comprehensive Income Loss Net Gain Loss Before Tax	$3.42M+37.5%	$2.49M-62.2%	$6.58M-15.9%	$7.82M-14.7%
Effective rate for interest on benefit obligation (percent)	——	——	——	——
Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Discount Rate	——	——	——	——
Expected long-term rate of return on plan assets	$0.070.0%	$0.070.0%	$0.070.0%	$0.070.0%
Defined Benefit Plan Benefit Obligation Period Increase Decrease	$1.5M+207%	-$1.4M-133%	-$600K+97.5%	-$24.3M-326%
Defined Benefit Plan, Expected Return (Loss) on Plan Assets	$4.36M-1.0%	$4.41M+6.7%	$4.13M-22.0%	$5.3M+2.7%
Interest cost	$3.53M+2.2%	$3.45M-5.3%	$3.65M+69.7%	$2.15M+19.1%
Defined Benefit Plan, Net Periodic Benefit Cost (Credit)	$1.24M-8.8%	$1.36M-43.9%	$2.42M+364%	$521K-46.1%
Service cost	$656K-9.0%	$721K-7.1%	$776K-27.9%	$1.08M+8.7%
Depreciation	$17.14M+3.2%	$16.61M+2.5%	$16.2M+0.9%	$16.06M-2.7%
Distribution expense	$52.5M+4.6%	$50.18M-6.6%	$53.7M+19.7%	$44.87M—
Dividends, Common Stock, Cash	$18.57M-24.8%	$24.68M+0.5%	$24.56M+1.6%	$24.18M+3.5%
Effect of exchange rate changes on cash, cash equivalents and restricted cash	$2.45M—	——	$473K—	——
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent	——	——	——	——
Contingent consideration	——	——	——	——
Contingent consideration	$2.37M+131%	-$7.53M-426%	-$1.43M—	——
Effect of cross-border tax laws	-$1.74M+38.2%	-$2.82M-21.5%	-$2.32M—	——
Effect of cross-border tax laws	——	——	——	——
Other	$0.08+310%	$0.02+53.8%	$0.01+145%	-$0.03-463%
State income taxes – net of federal income tax benefit	——	——	——	——
Changes in unrecognized tax benefits	——	——	——	——
Effective Income Tax Rate Reconciliation, Tax Credit, Percent	——	——	——	——
Share-Based Payment Arrangement, Expense, Tax Benefit	$3.7M-5.1%	$3.9M-2.5%	$4M+5.3%	$3.8M-2.6%
Gain (Loss), Foreign Currency Transaction, before Tax	-$1.08M+64.4%	-$3.04M—	——	——
Gain on sale of a product line	——	——	——	——
Foreign Currency Translation and Other Adjustments	——	——	——	——
Foreign currency translation and other adjustments	$1.65M+211%	-$1.49M+82.7%	-$8.59M-581%	-$1.26M—
Income Loss From Continuing Operations Before Income Taxes Domestic	$34.06M-72.6%	$124.4M+141%	$51.57M+154%	-$96.11M-312%
Income Loss From Continuing Operations Before Income Taxes Foreign	$37.05M-4.1%	$38.63M+32.0%	$29.26M+15.9%	$25.25M-9.3%
Federal taxes	$6.76M+87.8%	$3.6M+116%	$1.67M—	——
Foreign	$11.62M+27.5%	$9.12M-42.0%	$15.73M—	——
State taxes	$2.59M-32.5%	$3.84M+87.2%	$2.05M—	——
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount	$0—	$0+100%	-$424K—	——
Income Tax Reconciliation Foreign Income Tax Rate Differential	$3.2M-0.9%	$3.23M-4.6%	$3.39M—	——
Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount	$14.94M-56.4%	$34.24M+102%	$16.97M—	——
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount	$5.84M+75.9%	$3.32M+208%	$1.08M—	——
Effective Income Tax Rate Reconciliation, Other Adjustments, Amount	-$545K-398%	$183K+130%	-$617K—	——
Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount	$2.57M-6.3%	$2.74M+27.0%	$2.16M—	——
Changes in unrecognized tax benefits	-$684K-95.4%	-$350K—	$0—	——
Income Taxes Paid, Net	$20.98M+26.7%	$16.56M-14.9%	$19.45M—	——
Accounts payable	——	$15.35M+3.3%	$14.85M+2.6%	$14.48M+181%
Increase (Decrease) in Accounts Receivable	$2.36M+45.8%	$1.62M-96.6%	$47.07M—	——
Increase Decrease In Accrued Income Taxes Payable	-$558K-189%	-$193K+95.1%	-$3.92M-158%	$6.73M+502%
Accrued compensation and employee benefits	$14.91M—	——	$14.43M—	——
Increase (Decrease) in Inventories	——	$31.63M+325%	-$14.07M-118%	$78.56M+108%
Increase (Decrease) in Other Operating Assets	$13.16M-5.4%	$13.91M-36.7%	$21.98M+23.9%	$17.74M-26.1%
Other liabilities	$6.19M+246%	-$4.25M—	——	-$256K—
Add - Incremental shares under stock-based compensation plans (in shares)	——	——	——	$1.74M—
Interest Paid, Excluding Capitalized Interest, Operating Activity	$25.42M-22.2%	$32.65M-3.1%	$33.69M+29.2%	$26.08M+19.7%
Marketing	$67.25M+2.9%	$65.34M+7.3%	$60.92M+8.7%	$56.03M—
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation	-$135.82M+10.1%	-$151M-36.7%	-$110.43M-149%	$225M+322%
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation	-$20.96M-60.2%	-$13.08M+34.7%	-$20.03M+92.0%	-$249.53M-1,579%
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation	$170.69M+2.2%	$166.97M+33.2%	$125.35M—	——
Number of customer representing over 10% of consolidated net sales	0—	0—	0—	0—
Number of share-based compensation plans	1-50.0%	20.0%	20.0%	20.0%
Other Amortization Of Deferred Charges	$57.14M+3.4%	$55.25M-0.8%	$55.67M+4.1%	$53.46M-1.4%
Other Comprehensive Income Loss Before Tax	$11.73M+274%	-$6.75M-179%	$8.52M+500%	-$2.13M-114%
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax	——	——	——	——
Net gains (losses) deferred	——	$8.28M—	——	——
Tax on unrealized gain on derivative hedge agreements	——	$2.65M—	——	——
Cash flow hedges	——	$10.93M—	——	——
Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Before Tax	-$6.87M-224%	$5.52M+276%	-$3.14M-105%	-$1.53M-112%
Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax	——	$4.1M-37.3%	$6.54M-46.2%	$12.14M+499%
Unrealized gains (losses) on hedge instruments	——	——	——	——
Tax expense on reclassification of realized net derivative loss to net income	——	$1.31M-37.4%	$2.09M-46.1%	$3.88M+501%
Cash flow hedges, Gain or (loss) reclassified from accumulated OCI into income	——	$5.41M-37.3%	$8.63M-46.1%	$16.02M+500%
Foreign currency translation gains (losses)	——	——	——	——
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax	$15.17M+203%	-$14.75M-390%	$5.09M+160%	-$8.42M-19.0%
Other comprehensive income (loss)	$12.56M+245%	-$8.69M-213%	$7.69M+310%	-$3.66M-139%
Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax	——	——	——	——
Net gains/(losses) arising during the period	$2.01M+124%	$898K-79.8%	$4.45M-14.9%	$5.23M-10.4%
Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax	——	——	——	——
Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Before Tax	-$3.42M-37.5%	-$2.49M+62.2%	-$6.58M+15.9%	-$7.82M+14.7%
Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, before Tax	-$1.42M+11.1%	-$1.59M+25.3%	-$2.13M+17.8%	-$2.59M+22.2%
Tax expense (benefit)	-$834K-143%	$1.94M+133%	$832K-45.4%	$1.52M-71.1%
Payments for Contingent Consideration	$33.76M-40.6%	$56.88M+310%	$13.87M—	——
Payment for (Proceeds from) Other Investing Activity	——	$0-100%	$1M—	——
Payments for Repurchase of Common Stock	——	——	——	——
Payments of Ordinary Dividends, Common Stock	$24.75M+0.4%	$24.65M+0.6%	$24.5M+2.3%	$23.96M+3.0%
Payments to Acquire Property, Plant, and Equipment	$19.81M+51.4%	$13.08M-31.3%	$19.03M-12.6%	$21.79M+46.5%
Proceeds from revolver	$695.43M-7.4%	$751M+8.5%	$692M+50.4%	$460M+40.8%
Financing — other	$170K-94.0%	$2.83M-82.2%	$15.94M+88.0%	$8.48M—
Proceeds from sale of a product line	——	——	——	——
Cash received from option exercises	$200K-94.1%	$3.4M-79.0%	$16.2M+82.0%	$8.9M-54.6%
Warranty expense	$4.2M-14.3%	$4.9M+2.1%	$4.8M-18.6%	$5.9M-13.2%
Repayments of Lines of Credit	$695.43M-7.6%	$753M-0.9%	$760M+43.4%	$530M+34.6%
Payments on debt	$99.82M—	$0-100%	$20M—	——
Revenue From Contract With Customer Excluding Assessed Tax	$1.37B+5.2%	$1.31B+5.0%	$1.24B+19.1%	$1.05B+3.4%
Salesforce and commission expense	$237.7M+5.2%	$225.89M+4.7%	$215.8M+15.7%	$186.6M—
Segment Reporting, Other Segment Item, Amount	$22.1M+252%	$6.27M-40.2%	$10.48M-43.0%	$18.4M—
Stock-based compensation	$28.32M+10.8%	$25.56M+5.4%	$24.26M+11.6%	$21.73M+33.0%
Standard Product Warranty Accrual, Decrease for Payments	——	——	——	——
Current-period accruals	——	——	——	——
Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture	$1.04M-72.9%	$3.84M-77.2%	$16.83M+91.9%	$8.77M-23.0%
Treasury stock, value, acquired	——	——	——	——
Unrecognized tax benefits, settlements	$684K+95.4%	$350K—	$0—	$0—
Additions for tax positions of prior years	$0—	$0-100%	$1.5M—	$0—
Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations	$0-100%	$200K—	$0—	$0—
EBIT	$102.62M-48.8%	$200.33M+66.1%	$120.6M+69.5%	$71.15M-35.2%
EBITDA	$154.97M-38.4%	$251.63M+46.3%	$172M+42.3%	$120.91M-24.2%
EBITDA	$154.97M-38.4%	$251.63M+46.3%	$172M+42.3%	$120.91M-24.2%
EBITDA margin	11.3%-8.0pp	19.3%+5.4pp	13.8%+2.3pp	11.6%-4.2pp
EBIT	$102.62M-48.8%	$200.33M+66.1%	$120.6M+69.5%	$71.15M-35.2%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about CONMED.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is CONMED's revenue?: CONMED (CNMD) generated $1.4B in revenue over the trailing twelve months, up 4.1% year over year.
Is CONMED profitable?: CONMED reported $54.8M in net income over the trailing twelve months, a 4.0% net margin.
What are CONMED's profit margins?: Gross margin is 55.2% and operating margin is 8.2%, with a 4.0% net margin.
What is CONMED's earnings per share?: CONMED's diluted EPS over the trailing twelve months is $1.77.
Where does CONMED's income statement data come from?: Every line is extracted from CONMED's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.